Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Clinical trial NCT00607399 · TERMINATED
Trial details
- NCT number
- NCT00607399
- Sponsor
- SGX Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.